Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults

NCT00002427 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

225

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Hydroxyurea
DRUG: Stavudine
DRUG: Didanosine

Sponsor

Research Institute for Genetic and Human Therapy